← Back to Search

Genetic Analysis for Schizophrenia

N/A
Recruiting
Led By Herbert Y Meltzer, M.D.
Research Sponsored by Vanderbilt University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to find out if certain genes can predict how well a person will respond to the antipsychotic drug, clozapine.

Eligible Conditions
  • Schizophrenia
  • Bipolar Disorder
  • Depression
  • Schizoaffective Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: 1 Outcome in schizophrenia with certain antipsychoticActive Control2 Interventions
clozapine
Group II: 2 Outcome in schizophrenia with other AntipsychoticsActive Control2 Interventions
Other Antipsychotics

Find a Location

Who is running the clinical trial?

Vanderbilt UniversityLead Sponsor
710 Previous Clinical Trials
6,142,379 Total Patients Enrolled
9 Trials studying Schizophrenia
855 Patients Enrolled for Schizophrenia
Northwestern UniversityLead Sponsor
1,645 Previous Clinical Trials
957,594 Total Patients Enrolled
11 Trials studying Schizophrenia
1,145 Patients Enrolled for Schizophrenia
Herbert Y Meltzer, M.D.Principal InvestigatorVanderbilt University Medical Center
4 Previous Clinical Trials
510 Total Patients Enrolled
4 Trials studying Schizophrenia
510 Patients Enrolled for Schizophrenia

Media Library

1 Outcome in schizophrenia with certain antipsychotic Clinical Trial Eligibility Overview. Trial Name: NCT00178932 — N/A
Schizophrenia Research Study Groups: 1 Outcome in schizophrenia with certain antipsychotic, 2 Outcome in schizophrenia with other Antipsychotics
Schizophrenia Clinical Trial 2023: 1 Outcome in schizophrenia with certain antipsychotic Highlights & Side Effects. Trial Name: NCT00178932 — N/A
1 Outcome in schizophrenia with certain antipsychotic 2023 Treatment Timeline for Medical Study. Trial Name: NCT00178932 — N/A
Schizophrenia Patient Testimony for trial: Trial Name: NCT00178932 — N/A
~37 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top